You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

How Will You Manage These Patients With Recurrent Angioedema?

  • Authors: William R. Lumry, MD; Marc Riedl, MD
  • CME Released: 6/18/2020
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 6/18/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for allergists and clinical immunologists, pediatricians, and primary care physicians.

The goal of this activity is to educate physicians on diagnostic testing, patient evaluation, and management strategies as well as advances in the treatment of angioedema in order to optimize patient care.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Ordering tests to diagnose the cause of recurrent angioedema
    • Evaluating patients to identify candidates for changes in treatment strategy
    • Selecting acute and prophylactic treatment in patients with recurrent angioedema


Disclosures

AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

• Employment. Name of employer and job title.
• Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
• Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
• Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
• Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
• Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
• Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.


Moderator

  • Marc Riedl, MD

    Professor of Medicine
    Clinical Director
    US HAEA Angioedema Center
    University of California San Diego
    San Diego, California

    Disclosures

    Disclosure: Marc Riedl, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Adverum; Attune; Biocryst; CSL Behring; Kalvista; Pharming; Pharvaris; Takeda
    Served as a speaker or a member of a speakers bureau for: CSL Behring; Pharming
    Received grants for clinical research from: Biocryst; Ionis; Takeda

Faculty

  • William R. Lumry, MD

    Clinical Professor of Internal Medicine
    University of Texas Southwestern Medical School
    Dallas, Texas

    Disclosures

    Disclosure: William R. Lumry, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Biocryst; CSL Behring; Fresenius Kabi; Kalvista; Pharming; Shire/Takeda
    Served as a speaker or a member of a speakers bureau for: CSL Behring; Pharming; Shire/Takeda
    Received grants for clinical research from: ALK; Biocryst; CSL Behring; Gossamer; Green Cross; Ionis; Kalvista; Kedrion; Menlo; Shire/Takeda.
    Other: Board Membership at US Hereditary Angioedema Association Medical Advisory Board

Editors

  • Briana Betz, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

  • Renata Feldman, PharmD, RPh

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Renata Feldman, PharmD, RPh, has disclosed no relevant financial relationships.

CME Reviewers, AAAAI

  • Stuart L. Abramson, MD PhD AE-C FAAAAI

    Director, Allergy and Immunology Clinical Service

    Shannon Medical Center

    Disclosures

    Disclosure: Stuart L. Abramson, MD PhD AE-C FAAAAI, has disclosed no relevant financial relationships.

  • Kasey R. Strothman, MD FAAAAI

    Assistant Professor

    Nationwide Children's Hospital

    Disclosures

    Disclosure: Kasey R. Strothman, MD FAAAAI, has disclosed no relevant financial relationships.

Content Reviewer

  • Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Medscape and American Academy of Allergy Asthma and Immunology (AAAAI).

    For Physicians

  • The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AAAAI Privacy Policy To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at [email protected] .

    Contact this provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

How Will You Manage These Patients With Recurrent Angioedema?

Authors: William R. Lumry, MD; Marc Riedl, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 6/18/2020

Valid for credit through: 6/18/2021

processing....

Abbreviations

C1-INH = C1 esterase inhibitor
CT = computed tomography
ED = emergency department
GI = gastrointestinal
HAE = hereditary angioedema
IV = intravenous(ly)
SC = subcutaneous(ly)
WBC = white blood cell

« Return to: How Will You Manage These Patients With Recurrent Angioedema?
  • Print